The Filing Desk

Bio-Rad Laboratories vs Qiagen

Bio-Rad Laboratories BIO · Qiagen QGEN · Life Sciences Tools & Services

Bio-Rad Laboratories reported revenue of $2.6 billion in fiscal 2025, 1.2 times Qiagen's $2.1 billion in fiscal 2025. Bio-Rad Laboratories' revenue grew 0.7% in its latest year, and Qiagen's grew 5.7%. Bio-Rad Laboratories had an operating margin of 1.8%, against 22.3% at Qiagen. Free cash flow was $375 million at Bio-Rad Laboratories and $453 million at Qiagen.

Side by side

Bio-Rad LaboratoriesQiagen
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$2.6B$2.1B
Revenue growth0.7%5.7%
Revenue growth a year, last 5 years0.3%2.2%
Gross margin51.9%62.2%
Operating margin1.8%22.3%
Net margin29.4%20.3%
Free cash flow$375M$453M
Free cash flow margin14.5%21.7%
Return on capital0.5%9.9%
Net debt to EBITDA−1.6x0.8x
Dividends and buybacks$296M$334M
Change in diluted share count−3.3%−2.6%
Last close$367.50$49.63
P/E at the last close9.7×—
Insider trades, last 12 monthssold $1.4 million—
Piotroski F-score5 of 98 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Bio-Rad LaboratoriesQiagen
Operating margin
Percent of revenue
Bio-Rad LaboratoriesQiagen
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Bio-Rad LaboratoriesQiagen

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Bio-Rad Laboratories and Qiagen pages.